Tags: Zika Virus | zika | mosquitoes | virus

Feds Testing Zika Vaccine

Feds Testing Zika Vaccine

(Dreamstime)

By    |   Thursday, 29 September 2016 08:23 AM

The war against the Zika virus has a new front — a vaccine developed by the National Institutes for Health has entered Phase I clinical trials.

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH developed the vaccine, which does not contain the Zika virus, according to The Journal of the American Medical Association. It is based on an altered DNA strand that prompts an immune response against the virus, and has shown strong promise in animal testing. “NIAID worked expeditiously to ready a vaccine candidate, and results in animal testing have been very encouraging," reported NIAID Director Anthony S. Fauci, M.D.

The vaccine will be tested on 80 volunteers, ages 18-35, at the NIH in Maryland. According to the Centers for Disease Control and Prevention, there are 3,358 cases of Zika in the United States to date. With U.S. territories factored in, that number rises to 19,777.
 

© 2019 NewsmaxHealth. All rights reserved.

   
1Like our page
2Share
Health-News
The war against the Zika virus has a new front — a vaccine developed by the National Institutes for Health has entered Phase I clinical trials.
zika, mosquitoes, virus
153
2016-23-29
Thursday, 29 September 2016 08:23 AM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved